The COLOSSUS partners held an online meeting with the Project’s Scientific Advisory Board (SAB) on 11 March 2022. The team presented all our work to date and summarised results so far. Members of the SAB in attendance included experts in (1) medical oncology with specialist expertise in GI Oncology, molecular-targeted therapies, immunotherapy, multimodal treatment strategies and early drug developments (2) development and commercialisation of new diagnostics for personalised cancer care (3) computational oncology of colorectal cancer, multi-level genomic analyses of primary and metastatic cancers and (4) ethics in clinical research.
We are very grateful to the SAB members for their time, supportive assessment and expert input during the meeting. We will be following up with the SAB for further feedback in the weeks ahead. Thanks to all for a productive and successful day. We look forward to meeting in person next year.